Prabhudas Lilladher has given Buy recommendation for Ipca Laboratories with a target price of Rs. 2450 in its research report issued on Nov 17, 2021

Prabhudas Lilladher’s research report on Ipca Laboratories

IPCA Lab’s (IPCA) Q2 performance was weak and should recover from Q4FY22/Q1FY23. Domestic business (45% of total sales) continues to remain on strong footing and should continue to outperform IPM. Strong API capabilities and diversified model benefit IPCA in the current environment.

Outlook

We recommend ‘Buy’ rating on the stock with target price of Rs 2,450 based on 25x sept 2023E earnings. Any weakness in stock should be used as buying opportunity.

Leave a Reply

Your email address will not be published. Required fields are marked *